ctrl K

Price Alert

Anavex Life Sciences Corp... (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

9.91

-0.20 (-1.98%)

At close: Aug 15, 2025, 3:59 PM

10.26

3.48%

After-hours: Aug 15, 2025, 06:30 PM EDT

Anavex Life Sciences Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	132.19M	151.02M	149.16M	152.11M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	3.36M	3.55B	16.36K
Receivables	2.45M	2.71M	3.19M	9.14M
Inventory	n/a	n/a	n/a	16.36K
Other Current Assets	931K	653K	162.00	-16.36K
Total Current Assets	135.57M	154.39M	152.7M	161.62M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	3.36M	3.55B	16.36K
Total Assets	135.57M	154.39M	152.7M	161.62M
Account Payables	9.63M	4.32M	3.82M	4.74M
Deferred Revenue	842K	n/a	443.83K	443.83K
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	1.53M	6.85M	-47	n/a
Total Current Liabilities	15.3M	12.53M	10.21M	10.8M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.83M	n/a	n/a	-386
Total Long-Term Liabilities	4.83M	7.29M	4.27M	-386
Total Liabilities	15.3M	12.53M	10.21M	10.8M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	85K	82K	77.94K	75.92K
Retained Earnings	-336.07M	-293.07M	-245.56M	-197.59M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	120.26M	141.85M	142.49M	150.82M
Total Investments	n/a	n/a	n/a	n/a